Biogen Inc Stock Performance

BIIB Stock  USD 277.00  0.46  0.17%   
The firm shows a Beta (market volatility) of -0.0415, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biogen are expected to decrease at a much lower rate. During the bear market, Biogen is likely to outperform the market. Biogen Inc right now shows a risk of 0.0%. Please confirm Biogen Inc skewness, rate of daily change, and the relationship between the value at risk and accumulation distribution , to decide if Biogen Inc will be following its price patterns.

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Biogen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Biogen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more

Actual Historical Performance (%)

One Day Return
Five Day Return
Year To Date Return
Ten Year Return
All Time Return
7.3 K
Begin Period Cash Flow3.4 B

Biogen Relative Risk vs. Return Landscape

If you would invest  27,700  in Biogen Inc on March 18, 2024 and sell it today you would earn a total of  0.00  from holding Biogen Inc or generate 0.0% return on investment over 90 days. Biogen Inc is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Biogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   

Biogen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biogen Inc, and traders can use it to determine the average amount a Biogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Based on monthly moving average Biogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding Biogen to a well-diversified portfolio.

Biogen Fundamentals Growth

Biogen Stock prices reflect investors' perceptions of the future prospects and financial health of Biogen, and Biogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biogen Stock performance.

About Biogen Performance

To evaluate Biogen Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Biogen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Biogen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Biogen Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Biogen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 364.14  276.57 
Return On Tangible Assets 0.09  0.08 
Return On Capital Employed 0.06  0.08 
Return On Assets 0.04  0.06 
Return On Equity 0.08  0.10 

Things to note about Biogen Inc performance evaluation

Checking the ongoing alerts about Biogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biogen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Biogen Inc is not yet fully synchronised with the market data
Biogen Inc has a poor financial position based on the latest SEC disclosures
Over 93.0% of the company shares are held by institutions such as insurance companies
Evaluating Biogen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Biogen's stock performance include:
  • Analyzing Biogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biogen's stock is overvalued or undervalued compared to its peers.
  • Examining Biogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Biogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biogen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Biogen's stock. These opinions can provide insight into Biogen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Biogen's stock performance is not an exact science, and many factors can impact Biogen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings